Procaps Group S.A. (PROC)
NASDAQ: PROC · Real-Time Price · USD
2.510
+0.070 (2.87%)
Dec 20, 2024, 4:00 PM EST - Market closed
Procaps Group Employees
Procaps Group had 5,500 employees as of December 31, 2022. The number of employees increased by 507 or 10.15% compared to the previous year.
Employees
5,500
Change (1Y)
507
Growth (1Y)
10.15%
Revenue / Employee
$75,290
Profits / Employee
$9,491
Market Cap
283.19M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2022 | 5,500 | 507 | 10.15% |
Dec 31, 2021 | 4,993 | 207 | 4.33% |
Dec 31, 2020 | 4,786 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Accolade | 2,400 |
Amylyx Pharmaceuticals | 384 |
Vanda Pharmaceuticals | 203 |
4D Molecular Therapeutics | 147 |
C4 Therapeutics | 145 |
Foghorn Therapeutics | 116 |
Aclaris Therapeutics | 91 |
aTyr Pharma | 59 |
PROC News
- 1 day ago - Procaps Group Announces Key Shareholder and Board Decisions, Committee Restructuring, and Leadership Updates - GlobeNewsWire
- 18 days ago - Procaps Group Announces Financing, Shareholders Agreement and Board Updates - GlobeNewsWire
- 5 weeks ago - Procaps Receives Nasdaq Listing Determination; To Request Hearing and Further Stay Pending Hearing - GlobeNewsWire
- 2 months ago - Procaps Issues Shareholder Letter Update - GlobeNewsWire
- 3 months ago - Procaps Issues Shareholder Letter - GlobeNewsWire
- 6 months ago - Procaps Group Announces New Chairman - Business Wire
- 7 months ago - Procaps Group Receives Nasdaq Notice Related to Late Filing of its Form 20-F - Business Wire
- 7 months ago - Procaps Group Delays Filing of Annual Report on Form 20-F - Business Wire